Neurointerventional Devices Market Report 2025

The neurointerventional devices market size has grown strongly in recent years. It will grow from $2.57 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to rising awareness of early diagnosis, an increasing number of specialized neurointerventional centers, a higher prevalence of lifestyle-related diseases like hypertension and diabetes, growing demand for better patient outcomes, and strengthened support from public and private health organizations.

The neurointerventional devices market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth projected for the forecast period can be attributed to the increasing preference for image-guided surgeries, rising investment in neurovascular research, growing approvals of novel neurointerventional products, expanding partnerships and acquisitions among device manufacturers, and heightened demand for personalized treatment approaches. Key trends during this period include advancements in robotic-assisted neurointerventions, innovations in catheter and stent design, enhanced integration of artificial intelligence in diagnostic imaging, incorporation of augmented reality in surgical planning, and developments in embolization and thrombectomy techniques.

The increasing incidence of neurological disorders is expected to drive growth in the neurointerventional devices market going forward. Neurological disorders encompass any conditions affecting the brain, spinal cord, or nerves that disrupt normal functioning. This rise is largely attributed to an aging global population, as advancing age heightens the risk of neurodegenerative diseases due to natural declines in brain function and cellular repair. Neurointerventional devices assist in treating neurological disorders by enabling minimally invasive procedures to diagnose and manage conditions like brain aneurysms, strokes, and vascular malformations, which reduces risks, shortens recovery time, and improves patient outcomes. For example, according to a report by the Alzheimer's Association, a US-based nonprofit, 6.5 million Americans aged 65 and older were diagnosed with Alzheimer's dementia in 2022, rising to 6.9 million in 2024. Therefore, the growing incidence of neurological disorders is driving the neurointerventional devices market.

Key players in the neurointerventional devices market are focusing on technological innovations such as AI-assisted navigation systems to improve procedural accuracy, reduce intervention time, and enhance patient outcomes in complex neurovascular treatments. AI-assisted navigation systems use artificial intelligence algorithms to guide neurointerventional procedures in real time by analyzing medical imaging data. These systems provide enhanced visualization, automate path planning, and assist in accurately navigating devices through intricate brain vasculature, thereby increasing precision, shortening procedure durations, and minimizing risks. For instance, in October 2022, Medtronic plc, an Ireland-based healthcare technology company, launched the Medtronic Neurovascular Co Lab Platform to accelerate stroke treatment innovation. This platform encourages collaboration among startups, physicians, and institutions by offering a continuous virtual portal for submitting ideas, which are reviewed and supported through Medtronic’s expertise, funding, and network to rapidly develop promising neurovascular solutions and improve patient care.

In September 2024, Boston Scientific, a US-based medical technology company, acquired Silk Road Medical for approximately $1.18 billion. Through this acquisition, Boston Scientific aims to broaden its vascular surgery portfolio, strengthen its stroke prevention offerings, and accelerate its mission to transform treatment approaches for vascular disease. Silk Road Medical is a US-based company specializing in medical devices such as transcarotid artery revascularization systems, including the ENROUTE transcarotid neuroprotection and stent systems.

Major players in the neurointerventional devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Phenox GmbH, Balton Sp. z o.o., Zylox-Tonbridge Medical Technology Co. Ltd., Balt Group SAS, Veiva Scientific Co. Ltd., and InspireMD Inc.

North America was the largest region in the neurointerventional market in 2024. The regions covered in neurointerventional devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the neurointerventional devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurointerventional devices market consists of sales of catheters, stents, embolic coils, thrombectomy devices, and guidewires. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The neurointerventional devices market research report is one of a series of new reports that provides neurointerventional devices market statistics, including the neurointerventional devices industry global market size, regional shares, competitors with the neurointerventional devices market share, detailed neurointerventional devices market segments, market trends, and opportunities, and any further data you may need to thrive in the neurointerventional devices industry. This neurointerventional devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Neurointerventional devices are specialized medical instruments designed for minimally invasive procedures aimed at diagnosing and treating disorders of the blood vessels in the brain, spine, head, and neck. Their main function is to restore or enhance blood flow, remove clots, repair aneurysms, or address vascular malformations without requiring open surgery.

The primary types of neurointerventional devices include embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, flow diverters, intrasaccular devices, and others. Embolic coils are small, flexible metal devices used to block blood flow within aneurysms or abnormal vessels, encouraging clot formation to prevent rupture or bleeding. These devices are indicated for conditions such as brain aneurysms and strokes and are utilized through techniques like neurothrombectomy, cerebral angiography, stenting, coiling procedures, and flow disruption. The main end users consist of hospitals, ambulatory surgical centers, specialty clinics, and research institutions.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.